Beit Jala Pharmaceutical Company announced unaudited earnings results for the nine months ended September 30, 2019. For the period, the company reported sales of JOD 6,174,848 against JOD 5,106,829 a year ago. Net income after tax was JOD 905,218 against JOD 611,371 a year ago. Basic and diluted earnings per share were JOD 0.129 against JOD 0.087 a year ago.